Japan's regulatory agency gets 20% funding increase:
This article was originally published in Clinica
Executive Summary
The Pharmaceutical Affairs Bureau of Japan's Ministry of Health has been granted a 20.2% increase in funding in the fiscal 1996 budget to ¥,606 million ($90 million), reports Japan Medical Review. Among its priority projects for the current year, the bureau cites the international harmonisation of Japan's regulations covering in vitro diagnostics and medical devices as well as improving the safety of blood preparations.